GlassScriptPhysician profile
Christopher P Walsh
NPI 1710275151
$1,732.62
in general payments reported to CMS, 2019-2025
20 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $189 · 2021: $124 · 2022: $258 · 2023: $442 · 2024: $133 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $848.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $535.67 | 2019-2025 | Orthovisc, Monovisc |
| Zimmer Biomet Holdings, INC. | $440.62 | 2023-2025 | Persona, Mymobility Platform, Rosa |
| Stryker Corporation | $189.38 | 2019-2024 | Blueprint Patient Specific Instrumentation, Aequalis Perform+, Tornier Perform Reversed Augmented Glenoid |
| Sanara Medtech INC. | $130.69 | 2020 | |
| Medacta USA, INC. | $58.39 | 2023-2025 | Reverse Shoulder, Gmk Revision |
| Providence Medical Technology, INC. | $51.25 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $46.82 | 2020-2023 | Zilretta, Iovera, Exparel |
| Heraeus Medical, LLC. | $39.30 | 2025 | |
| Heron Therapeutics, INC. | $37.30 | 2022-2024 | Zynrelef |
| Axogen | $24.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $23.85 | 2023 | |
| Spr Therapeutics, INC | $23.51 | 2023 | Sprint Pns System |
| Curonix LLC | $21.65 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Dynasplint Systems INC. | $19.84 | 2025 | Dynasplint |
| Medtronic, INC. | $18.43 | 2024 | Kyphon Express II Kyphopak Tray |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $15.82 | 2020 | |
| Kerecis Limited | $15.60 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Innovation Technologies INC | $14.99 | 2025 | Irrisept |
| Si-Bone, INC. | $13.42 | 2023 | |
| Hollister Incorporated | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.